InvestorsHub Logo
Followers 85
Posts 7193
Boards Moderated 0
Alias Born 02/03/2018

Re: Jasbg post# 289402

Monday, 08/03/2020 10:58:52 AM

Monday, August 03, 2020 10:58:52 AM

Post# of 427579
Jasbg, PSK-9 inhibitors have been a around and approved for several years now. It doesn't address Trigs at all, which is 65% of the remaining risk when LDL-C is well managed with Statin or PSK-9's. If anything, PSK-9'S would be prescribed with Vascepa to cover the entire @risk pop.

ILT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News